Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Zimmer Looks To Score Big In Chinese Orthopedic Market With Beijing Montagne Acquisition

This article was originally published in PharmAsia News

Executive Summary

U.S.-listed orthopedic device maker Zimmer Inc. says its latest overseas purchase of Beijing Montagne Medical Device Co. Ltd., gives it greater marketing access to the Chinese orthopedic implant market, growing at an estimated 15 percent annually, and a manufacturing base to compete with rivals already in the market

You may also be interested in...



China Device Market May Gain As Reforms Favor Diagnostics And Prevention

China’s medical device market is posed to overtake France as the third largest by 2020 and pull even domestically with pharmaceuticals in coming years as government health care reforms put emphasis on diagnostics and prevention.

China Device Market Looks Set To Gain In 2013 As Health Care Reforms Favor Diagnostics

China’s medical device market is posed to overtake France as the third largest by 2020 and pull even domestically with pharmaceuticals in coming years as government health care reforms put emphasis on diagnostics and prevention.

A Closer Look: Changes To China’s Orthopedics Market Fuel Deals Like Stryker-Trauson

Large domestic players like Trauson could benefit from new guidelines mandating centralized purchases for high-value medical consumables.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

SC076357

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel